$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform
05:54am, Thursday, 30'th Sep 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart coronavirus detection test in US and globally Amassed balance sheet of $72.4 million What Co-Diagnostics does:
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform for the masses
05:53am, Thursday, 30'th Sep 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart coronavirus detection test in US and globally Amassed balance sheet of $72.4 million What Co-Diagnostics does:
Co-Diagnostics, Inc. has said it will be introducing its upcoming at-home and point-of-care PCR device at a press conference at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo being held
Co-Diagnostics announces corporate rebranding after period of transformative growth and expansion
10:47am, Thursday, 23'rd Sep 2021
Co-Diagnostics Inc. is rebranding its image to better reflect its growing scope, mission, and upcoming expansion into new diagnostics verticals.
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion
09:30am, Thursday, 23'rd Sep 2021
SALT LAKE CITY, Sept. 23, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular d
Co-Diagnostics says its Logix Smart ABC Test is authorized for use in Mexico
10:56am, Tuesday, 21'st Sep 2021
Co-Diagnostics Inc has announced that its Logix Smart Influenza A/Influenza B/COVID-19 "ABC" Test has been approved for sale in Mexico by the Mexican Department of Epidemiology (InDRE) after the depa
Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico
09:30am, Tuesday, 21'st Sep 2021
SALT LAKE CITY, Sept. 21, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced
Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference
05:03pm, Monday, 20'th Sep 2021
SALT LAKE CITY, Sept. 20, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics says its CoSara JV received regulatory clearance in India for Saragene dengue and chikungunya tests
01:42pm, Thursday, 16'th Sep 2021
Co-Diagnostics (NASDAQ:CODX) Inc has announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control
Co-Diagnostics says its CoSara JV received regulatory clearance in India for Saragene dengue and chikunguny tests
10:36am, Thursday, 16'th Sep 2021
Co-Diagnostics Inc has announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control Organization (
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests
09:30am, Thursday, 16'th Sep 2021
SALT LAKE CITY, Sept. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular
Co-Diagnostics says its Logix Smart COVID-19 Test Kit used to confirm presence of coronavirus including mutated strains in Italy
10:25am, Wednesday, 08'th Sep 2021
Co-Diagnostics Inc. reports that its Logix Smart COVID-19 Test Kit was used by Italian researchers to confirm the presence of SARS-CoV-2, including mutated strains of the virus.
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
09:30am, Wednesday, 08'th Sep 2021
SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced t
Why Co-Diagnostics Is A Solid Covid-19 Play
01:54am, Thursday, 19'th Aug 2021
Why Co-Diagnostics Is A Solid Covid-19 Play
CoDiagnostics, Inc. (CODX) Just Reclaimed the 20-Day Moving Average
11:26am, Monday, 16'th Aug 2021
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Sign In
Buy CODX